Publicaciones en colaboración con investigadores/as de Institució Catalana de Recerca i Estudis Avançats (7)

2018

  1. P95HER2–T cell bispecific antibody for breast cancer treatment

    Science Translational Medicine, Vol. 10, Núm. 461

  2. RAD51 foci as a functional biomarker of homologous recombination repair and PARP inhibitor resistance in germline BRCA-mutated breast cancer

    Annals of Oncology, Vol. 29, Núm. 5, pp. 1203-1210

2016

  1. Modeling anti-IL-6 therapy using breast cancer patient-derived xenografts

    Oncotarget, Vol. 7, Núm. 42, pp. 67956-67965

2015

  1. Effect of cellular senescence on the growth of HER2-positive breast cancers

    Journal of the National Cancer Institute, Vol. 107, Núm. 5

  2. Patterns of HER2 gene amplification and response to anti-HER2 therapies

    PLoS ONE, Vol. 10, Núm. 6

2014

  1. Effect of p95HER2/611CTF on the response to trastuzumab and chemotherapy

    Journal of the National Cancer Institute, Vol. 106, Núm. 11

2013

  1. A dominant-negative N-terminal fragment of HER2 frequently expressed in breast cancers

    Oncogene, Vol. 32, Núm. 11, pp. 1452-1459